Press Releases
🇺🇸 FDA Page 16FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Access critical pharma & biotech press releases. Stay ahead on drug approvals, clinical trials, M&A, and regulatory updates impacting global markets.
Showing 181–192 of 212 articles
FDA Reauthorizes Philip Morris IQOS as Modified Risk Tobacco Product for Continued U.S. Marketing
Olema Oncology Presents Palazestrant and OP-3136 Preclinical Data at AACR 2026 for Breast Cancer Treatment
UCB Acquires Neurona Therapeutics for NRTX-1001 Epilepsy Cell Therapy in $XXX Million Deal
argenx VYVGART Shows Promise Across Multiple Myasthenia Gravis Subtypes in New AAN 2026 Clinical Data
Nuvalent's Zidesamtinib Shows Promise in ROS1-Positive Lung Cancer Patients at AACR 2026
MAIA Biotechnology Activates First U.S. Site for Phase 2 Telomere-Targeting NSCLC Treatment Trial
Dr. Falk Pharma and Renexxion Announce Naronapride Phase 2b Gastroparesis Results at DDW 2026
Medera's AAV-SERCA2a Gene Therapy Receives FDA Fast Track Designation for Duchenne Muscular Dystrophy Cardiomyopathy
Boehringer Ingelheim's Zongertinib Shows Promise for HER2-Mutant Lung Cancer in NEJM Study
Mabwell's MAIWEIJIAN Denosumab Injection Receives NMPA Acceptance for Expanded Cancer Bone Complications Treatment
Sedogen Receives U.S. Patent for Diazoxide Treatment of Prader-Willi Syndrome Behavioral Symptoms
Mabwell's LILRB4/CD3 Bispecific Antibody 6MW5311 Receives NMPA IND Approval for Leukemia Treatment